HOME >> MEDICINE >> NEWS
Study reveals frequent non-guideline treatment of late-life depression

A new study documenting the treatment of late-life depression by Canadian health professionals will be presented today at the American Psychosomatic Society Annual Meeting in Vancouver, Canada. The study is the first to assess whether people diagnosed with late-life depression receive 'guideline concordant pharmacotherapy'--medication recommended in guidelines issued by the Canadian Psychiatric Association.

The research, conducted by Dr. Maida Sewitch at the McGill University Health Centre (MUHC) in Montreal and funded by the Canadian Institutes of Health Research (CIHR), followed the initial medication dispensed to over 5258 Quebec seniors, immediately following diagnosis of depression.

Almost all the seniors studied (84%) were given some form of medication, but incredibly only slightly more than half (55%) were given the recommended first-line antidepressants according to the Canadian Psychiatric Association. "The rest (45%) were given other drugs, some of which are known to be unhelpful for depression, especially in the elderly," explains Dr. Sewitch.

One medication--a group of psychotropic drugs known as benzodiazepines--was dispensed to nearly 2000 of the study's late-life depression patients. "There is evidence to suggest that this group of drugs may worsen depression or result in cognitive problems and falls in the elderly," says Dr. Sewitch.

The study also suggests that men--commonly diagnosed by psychiatrists in hospital settings--are more likely to receive guideline concordant medication than women--commonly diagnosed by general practitioners in out-patient settings. "These results highlight possible worrisome errors in the diagnosis and treatment of late-life depression," says Dr. Sewitch. "Further research is required in order to unravel the complexities."


'"/>

Contact: Ian Popple
ian.popple@muhc.mcgill.ca
514-843-1560
McGill University
3-Mar-2005


Page: 1

Related medicine news :

1. Study of energy and health in Africa focuses spotlight on charcoal and forest management
2. Study shows promise in identifying kidney failure
3. Study shows patch therapy may be as effective as oral medications
4. Study shows soy is well accepted in school lunches
5. Study finds that coordinating care of chronically ill patients does not increase liability
6. Study provides new estimates of the causes of child mortality worldwide
7. Study finds factors linked to substance use disorder relapse among health care professionals
8. Study finds majority of women willing to accept cervical cancer vaccine for self and children
9. Study shows use of budesonide reduced the risk of asthma related events by 40% in children
10. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased
11. Study shows acrylamide in baked and fried food does not increase risk of breast cancer in women

Post Your Comments:
(Date:6/18/2013)... clinical researchers have launched an innovative clinical trial, ... ability of a patient,s own stem cells to ... disease (PAD). , Led by Vik Kashyap, ... Case Medical Center,s Harrington Heart & Vascular Institute ... University School of Medicine, the clinical trial is ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 The July 2013 ... Cheater’s Guide to Getting Beach Ready,” offers a list of ... look their best in a bathing suit this summer. The ... skin firming , smoothing cellulite , and more. (go ... Ourian, Medical Director of Epione Beverly Hills, “though I would ...
(Date:6/18/2013)... Healthcare Solutions , the parent ... today announced the appointment of Richard Leonardo to ... position, Leonardo will direct Healthcare Solutions’ national sales ... initiatives. , Recognized in the property and casualty ... more than 20 years of experience in business ...
(Date:6/18/2013)... Calif. (PRWEB) June 18, 2013 David ... professor of Family Medicine for the College of Osteopathic ... Health Sciences has been elected president of the ... Edmund G. Brown Jr. appointed Connett, a 1984 alumnus ... OMBC members recently elected Connett to the position during ...
(Date:6/18/2013)... the mammary gland appear to provide a crucial link ... and the subsequent development of breast cancer, researchers from ... issue of the journal Cancer Prevention Research . ... with an increased risk of certain types of aggressive ... social stress to cancer have been hard to identify. ...
Breaking Medicine News(10 mins):Health News:UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation 2Health News:Skin Care – Getting Your Body Beach Ready 2Health News:Healthcare Solutions Appoints Richard Leonardo to Chief Sales Officer 2Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 2Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 3Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 4
(Date:6/17/2013)... PAUL, Minn. , June 17, 2013 Prime ... branding and design agency, Larsen, was awarded the Silver Anvil ... Repositioning Prime Therapeutics." The award was presented at the Public ... Ceremony held June 13 at the AXA Equitable ... The Silver Anvil, which has been presented annually ...
(Date:6/17/2013)... , June 17, 2013 /PRNewswire-iReach/ -- Weiler ... company,s new X-4S pressure sensitive labeling head. The ... speed and performance requirements that serialization demands. ... WLS is uniquely qualified to work with pharmaceutical ... their serialization and track and trace implementation strategies. ...
(Date:6/17/2013)... Mass. and TORONTO , ... ) (OTCBB:GNBT) today announced that it entered into a ... 17, 2013.  The investors have agreed to purchase in ... the Company,s newly designated non-voting Series E 9% Convertible ... up to an aggregate of 100% of the shares ...
Breaking Medicine Technology:Prime Therapeutics receives prestigious Silver Anvil Award from Public Relations Society of America 2Weiler Labeling Introduces Serialization-Capable X-4S Labeling Head 2Generex Announces $1,225,000 Capital Investment 2Generex Announces $1,225,000 Capital Investment 3Generex Announces $1,225,000 Capital Investment 4Generex Announces $1,225,000 Capital Investment 5
Cached News: